Chris Ogden
Chief Financial Officer
Replay available
CytomX Therapeutics, Inc. (CTMX) Q2 2026 Earnings Call
CytomX Therapeutics, Inc. (NASDAQ: CTMX) Q2 2026 earnings conference call, held 2026-08-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Sean McCarthy
Chief Executive Officer and Chairman
Edward Tenthoff
Equity Research Analyst at Piper Sandler
Olivia Brea
Analyst at Cancer Fitzgerald
Matthew Beigler
Analyst at Opco
Joy Son
Analyst at J.P. Morgan (for Anupam Rama)
Etta Daru
Analyst at Barclays
Mitchell Kapoor
Analyst at H.C. Wainwright
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Cytomx Therapeutics, Inc..
Replay transcript excerpt
[Speaker identities could not be resolved; generic labels used] [00:00] Speaker 1: Good afternoon, everyone. Thank you for standing by. Welcome to the Cytomex Therapeutics 3rd 0.25 2025 [00:06] Speaker 1: financial results call. Please be advised that today's call is being recorded. [00:11] Speaker 1: I would now like to hand the call over to your host for today, Chris Ogden, Cytomex's [00:15] Speaker 1: Chief Financial Officer. Please go ahead. [00:20] Speaker 2: Thank you. Good afternoon and thank you for joining us. [00:23] Speaker 2: Before we begin, I'd like to remind everyone that during this call, we'll be making 4 looking statements. [00:29] Speaker 2: Because 4 looking statements relate to the future, [00:32] Speaker 2: they're subject to inherent uncertainties and risks that are difficult to predict and many of which are outside of our control. [00:40] Speaker 2: Important risks and uncertainties are set forth in our most recent public filings [00:45] Speaker 2: with the SEC at sec.gov. [00:48] Speaker 2: We undertake no obligation to update any for looking statements, whether as a result of new information, future developments, or otherwise. [00:57] Speaker 2: Earlier this afternoon, we issued a press release that includes a summary of our 3rd 0.25 [01:02] Speaker 2: 2025 [01:03] Speaker 2: financial results [01:04] Speaker 2: and highlights recent progress at Citomics. [01:07] Speaker 2: We encourage everyone to read today's press release and the associated materials [01:12] Speaker 2: which have been filed with the SEC. [01:15] Speaker 2: Additionally, the press release recording of this call and our SEC filings can be found under the investors [01:21] Speaker 2: and news section of our website. [01:25] Speaker 2: With me on the call today is Dr. Sean Mc...